Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/04/013411
CTRI/2018/04/013411
Recruiting
未知

An interventional study:Efficacy and safety of homologous platelet concentrate for the treatment of diabetic foot ulcers

Self sponsored0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Patients with diabetic foot ulcers

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Patients with diabetic foot ulcers
Sponsor
Self sponsored
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.persons with type1 or type2 diabetes with denovo lower extremity diabetic ulcers
  • •2\.male and female,between ages 18\-95
  • •3\.ulcer of atleast 4weeks duration with post debridement free of sinus tracts and tunneling and atleast 4cms from any additional wound
  • •4\.HbA1C \<12
  • •5\.Wound measurement between 0\.5 \- 20 sqcm
  • •6\.full thickness without exposure of bone, muscle, ligament, tendon
  • •7\.the limb had to have adequate perfusion via ABI between 0\.8 \-1\.5
  • •8\.no H/O infectious disorders in last 6 months
  • •9\.informed consent form signed

Exclusion Criteria

  • •1\. Non pregnant and non lactating women
  • •2\. Not on suppressants and ART
  • •3\. Ulcers of venous and arterial insufficiency
  • •4\. Bleeding and Clotting disorders
  • •5\. Patients on chemo and radiotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
on-interventional study on the safety and efficacy of an Abraxane(R) mono therapy for the therapy of patients with metasasized breast cancer with special consideration of the toxicity profilesC50Malignant neoplasm of breast
DRKS00003203OnkoDataMed GmbH !450
Not yet recruiting
Phase 3
A randomized control trial to study the antibody response and side effects after the booster dose of COVID-19 vaccine
CTRI/2022/01/039677Institute of Liver and Biliary Sciences
Recruiting
Not Applicable
on-interventional study about safety and efficacy of chemo-therapy with Paclitaxel Stragen(R) / Eurotaxel(R) (new name of the prescription) as mono or combined therapy for routine treatment of ovarial or breast cancer with special consideration of age and BMI starting position.Breast cancer, ovarial cancer
DRKS00000781apharm GmbH1,500
Not yet recruiting
Not Applicable
The intervention trial of safety and efficacy of once-weekly Trelagliptin switched from daily DPP4 inhibitors for elderly patients with type 2 diabetesType 2 diabetes
JPRN-UMIN000026319Kanagawa-ken Keiyu-kai Keiyu hospital30
Completed
Not Applicable
A clinical study of the Safety and effectiveness of Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) treatment for the palliation of painful bone metastases
JPRN-UMIN000012441Department of Orthopaedic Surgery, Kochi Medical School, Kochi University25